Interaction of SMAC/Diablo with a survivin/BIRC5-derived peptide alters essential cancer hallmarks: tumor growth, inflammation, and immunosuppression
Article in Molecular Therapy (April 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Molecular Therapy (April 2024)
Preprint in Research Square (March 2024)
Article in Journal of Drug Targeting (February 2024)